Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Keybanc Downgrades Inovalon Holdings to Sector Weight

Keybanc analyst Donald Hooker downgrades Inovalon Holdings (NASDAQ:INOV) from Overweight to Sector Weight.

byBenzinga Newsdesk

August 25, 2021

1 minute read

Keybanc analyst Donald Hooker downgrades Inovalon Holdings (NASDAQ:INOV) from Overweight to Sector Weight.

Credit Suisse Maintains Outperform on HollyFrontier, Raises Price Target to $44

By Benzinga Newsdesk

Today, 5:15 AM

Credit Suisse analyst Manav Gupta maintains HollyFrontier (NYSE:HFC) with a Outperform and raises the price target from $42 to $44.

HFC

Analyst Ratings

What 4 Analyst Ratings Have To Say About Biomarin Pharmaceutical

By Benzinga Insights

Today, 5:15 AM

Analysts have provided the following ratings for Biomarin Pharmaceutical (NASDAQ:BMRN) within the last quarter:

BMRN

iRadimed Q3 EPS $0.45 Up From $0.23 YoY

By Benzinga Newsdesk

Today, 5:15 AM

iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.45 per share. This is a 95.65 percent increase over earnings of $0.23 per share from the same period last year.

IRMD

Criteo Q2 Bottom-Line Surpass Street View

By Akanksha Bakshi

Today, 5:15 AM

Criteo S.A. (NASDAQ:CRTO) reported a second-quarter FY22 contribution ex-TAC decline of 3% Y/Y to $215 million, missing the consensus…

CRTO

Keybanc Downgrades Inovalon Holdings to Sector Weight

Related Posts

Credit Suisse Maintains Outperform on HollyFrontier, Raises Price Target to $44

What 4 Analyst Ratings Have To Say About Biomarin Pharmaceutical

iRadimed Q3 EPS $0.45 Up From $0.23 YoY

Criteo Q2 Bottom-Line Surpass Street View